Department of Pathology and Immunology.
Department of Integrative Physiology and Biophysics, and.
J Clin Invest. 2024 Jan 2;134(1):e176089. doi: 10.1172/JCI176089.
Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder caused by an unstable expanded CTG repeat located in the 3'-UTR of the DM1 protein kinase (DMPK) gene. The pathogenic mechanism results in misregulated alternative splicing of hundreds of genes, creating the dilemma of establishing which genes contribute to the mechanism of DM1 skeletal muscle pathology. In this issue of the JCI, Cisco and colleagues systematically tested the combinatorial effects of DM1-relevant mis-splicing patterns in vivo and identified the synergistic effects of mis-spliced calcium and chloride channels as a major contributor to DM1 skeletal muscle impairment. The authors further demonstrated the therapeutic potential for calcium channel modulation to block the synergistic effects and rescue myopathy.
肌强直性营养不良 1 型(DM1)是一种常染色体显性疾病,由位于 DM1 蛋白激酶(DMPK)基因 3'-UTR 中的不稳定扩展 CTG 重复序列引起。致病机制导致数百个基因的异常剪接调控,从而产生了确定哪些基因有助于 DM1 骨骼肌病理机制的难题。在本期 JCI 中,Cisco 及其同事系统地测试了 DM1 相关异常剪接模式在体内的组合效应,并确定了异常剪接的钙和氯离子通道的协同作用是导致 DM1 骨骼肌损伤的主要因素。作者进一步证明了钙通道调节的治疗潜力,以阻断协同作用并挽救肌病。